Wed 25 Nov 2009 | 11:54 EST

You are here: Home > News > Article

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Bristol-Myers says FDA approves new 300mg loading dose tablet for Plavix

Thu Sep 27, 2007 9:00am EDT

Email | Print |

Share

| Reprints | Single Page

[-] Text [+]

Sanofi-aventis (SNY) and BMY announce that the FDA has approved a supplemental new drug applicatio for a 300mg tablet of the antiplatelet Plavix.

© Thomson Reuters 2009 All rights reserved

Share:

also on reuters

Reuters Summit: India Investment

Full Coverage: Reuters India Investment Summit

Recreating the Big Bang

Slideshow: Recreating the Big Bang

The first biofuel passenger flight

Video: The first biofuel passenger flight

More InPlay Briefing.com

Insight Enterprises' board authorizes additional $50 mln stock repurchase

Ampex and Hillside agree to 60 day extension to standstillaAgreement; engages Commercial Strategy to pursue licensing efforts

New Oriental reports Q2 EPS of $0.07 vs $0.10 in 2Q07; revs rose 129% to $18.2 mln - no ests

General Steel reports Q3 EPS of $0.25 vs $0.20 two analyst est; revs rose $636% YoY to $345.4 mln vs $289.86 mln two analyst est

Ansoft beats by $0.01, reports revs in-line

More InPlay Briefing.com News...

Featured Broker sponsored link

Editor's Choice

Six-month-olds Philip Hanekom (L), Sadie Jimenez (C), and Kyla White sporting homemade crowns are held by family friends as they wait for Britain's Queen Elizabeth

A selection of our best photos from the past 24 hours. Slideshow

Most Popular on Reuters

Articles
Video

Most Popular Articles RSS Feed

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.